“Any senior scientist will tell you that the biggest conflict of interest he or she has doesn’t have anything to do with the [corporate or other] interests that they list on their PowerPoints or at the end of their publications,” Dr. Paul M. Ridker said recently during his presentation on the inflammatory hypothesis of atherosclerosis at the annual meeting of the International Society on Hypertension in Blacks. “It has to do with our individual belief in the biology of what we’re doing.”É um cenário bastante interessante e controverso. Luis Cláudio Correia, do Blog Medicina Baseada em Evidências, tirou do estudo citado acima inspiração para várias postagens. Veja só clicando aqui.
Dr. Ridker’s contention is likely a nod to the diatribe that followed the publication of results from the 2008 JUPITER trial on the effects of rosuvastatin (Crestor) in which he and his co-investigators attributed a 44% reduction in cardiovascular events to the agent’s ability to both lower LDL cholesterol and reduce C-Reactive Protein (CRP) levels (N. Engl. J. Med. 2008 Nov. : 2195-207). [READ FULL ARTICLE]
quarta-feira, 13 de julho de 2011
Medicina Baseada em Evidências, conflitos de interesse e cardiologia
Publicaram ontem: Money is Only Part of the COI Story